SELLAS Life Sciences (SLS) Goodwill & Intangibles (2011 - 2026)
SELLAS Life Sciences (SLS) reported Goodwill & Intangibles of $1.9 million for Q1 2026, little changed year-over-year from $1.9 million in Q1 2025, and little changed on a QoQ basis from $1.9 million in Q4 2025.
SELLAS Life Sciences (SLS) has 16 years of Goodwill & Intangibles data on file, last reported at $1.9 million in Q1 2026.
- Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $1.9 million, up 0.74% from the prior year.
- Goodwill & Intangibles was little changed at $1.9 million in Q1 2026 per SLS's latest filing, from $1.9 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.9 million in Q1 2022 and bottomed at $1.9 million in Q4 2023.
- The 5-year median for Goodwill & Intangibles is $1.9 million (2022), against an average of $1.9 million.
- The widest annual swing landed in 2022, when Goodwill & Intangibles rose 0.74%; it then decreased 0.73% in 2023.
- Tracing SLS's Goodwill & Intangibles over 5 years: stood at $1.9 million in 2022, then slipped by 0.73% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then rose by 0.74% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
- Per Business Quant, the three latest SLS Goodwill & Intangibles figures stand at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 1.91 Mn |
| Dec 31, 2021 | 1.90 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |
| Mar 31, 2021 | 1.91 Mn |
| Dec 31, 2020 | 1.91 Mn |
| Sep 30, 2020 | 1.91 Mn |
| Jun 30, 2020 | 1.91 Mn |
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 1.91 Mn |
| Sep 30, 2019 | 1.91 Mn |
| Jun 30, 2019 | 1.91 Mn |
| Mar 31, 2019 | 1.91 Mn |
| Dec 31, 2018 | 1.90 Mn |
| Sep 30, 2018 | 1.91 Mn |
| Jun 30, 2018 | 1.91 Mn |
| Mar 31, 2018 | 1.91 Mn |
| Dec 31, 2017 | 19.50 Mn |
| Sep 30, 2017 | 13.49 Mn |
| Jun 30, 2017 | 15.15 Mn |
| Mar 31, 2017 | 15.15 Mn |
| Dec 31, 2016 | 15.15 Mn |
| Sep 30, 2016 | 15.15 Mn |
| Jun 30, 2016 | 15.15 Mn |
| Mar 31, 2016 | 15.15 Mn |
| Dec 31, 2015 | 15.15 Mn |
| Sep 30, 2015 | 15.15 Mn |
| Jun 30, 2015 | 15.32 Mn |
| Mar 31, 2015 | 15.32 Mn |
| Dec 31, 2014 | 15.15 Mn |
| Sep 30, 2014 | 15.05 Mn |
| Jun 30, 2014 | 8.21 Mn |
| Mar 31, 2014 | 8.01 Mn |
| Dec 31, 2013 | 5.90 Mn |
| Sep 30, 2013 | 5.90 Mn |
| Jun 30, 2013 | 5.90 Mn |
| Mar 31, 2013 | 5.90 Mn |
| Dec 31, 2012 | 5.90 Mn |
| Sep 30, 2012 | 5.90 Mn |
| Mar 31, 2012 | 5.90 Mn |
| Dec 31, 2011 | 5.90 Mn |
| Sep 30, 2011 | 845,000.00 |
| Jun 30, 2011 | 845,000.00 |